BioSpace News Archive

Evelo Biosciences (NASDAQ:EVLO), a clinical stage biotechnology company developing a new modality of orally delivered, systemically acting biologics, today announced that it will host a conference call and live webcast at 8:30 A.M. ET on Tuesday, November 5, 2019 to report its third quarter financial results and discuss recent business updates.

New WebMD-The John A. Hartford Foundation Survey Finds Many Incorrectly Believe Depression, Dementia and Lack of Mobility are Inevitable

Coalition for Epidemic Preparedness Innovations (CEPI) partnership will support Themis’ development and manufacturing of vaccine candidate

CHC Health has announced a strategic partnership with Catalyst Healthcare, an award-winning technology company, and Pack4U for delivery of connected care at home, to provide virtual pharmacist services for improving medication adherence and patient health outcomes.

Companies collaborate to help improve the lives of patients with multiple chronic conditions

Bio-Techne Corporation reported its financial results for the first quarter ended September 30, 2019.

Femtogenix Ltd announced data demonstrating the potent efficacy and favourable toxicity profile of a reduced potency analogue from its Pyridinobenzodiazepine ADC payload platform in solid tumour models.

Waters Corporation announced third quarter 2019 sales of $577 million, which were flat as reported, compared to sales of $578 million for the third quarter of 2018.

Merck, known as MSD outside the United States and Canada, announced financial results for the third quarter of 2019.

Sunesis Pharmaceuticals, Inc. announced that it will host a conference call on Tuesday, November 12th, 2019 at 4:30 p.m. Eastern Time to discuss corporate updates and financial results for the third quarter ended September 30, 2019..